The molecular topology model and discriminant analysis have been applied to
the prediction of some pharmacological properties of hypoglycemic drugs us
ing multiple regression equations with their statistical parameters. Regres
sion analysis showed that the molecular topology model predicts these prope
rties. The corresponding stability (cross-validation) studies performed on
the selected prediction models confirmed the goodness of the fits. The meth
od used for hypoglycemic activity selection was a linear discriminant analy
sis (LDA). We make use of the pharmacological distribution diagrams (PDDs)
as a visualizing technique for the identification and selection of new hypo
glycemic agents, and we tested on rats the predictive ability of the model.